CREDIT SUISSE AG/ - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$172,000
-63.2%
60,077
-1.4%
0.00%
Q2 2019$467,000
-39.7%
60,943
+4.7%
0.00%
-100.0%
Q1 2019$774,000
-37.2%
58,222
-26.3%
0.00%0.0%
Q4 2018$1,232,000
-19.2%
79,050
+1.9%
0.00%0.0%
Q3 2018$1,525,000
-28.0%
77,584
+5.2%
0.00%
-50.0%
Q2 2018$2,118,000
+8.7%
73,784
-10.5%
0.00%0.0%
Q1 2018$1,949,000
+1.5%
82,406
-8.1%
0.00%0.0%
Q4 2017$1,921,000
-20.9%
89,633
-12.7%
0.00%0.0%
Q3 2017$2,428,000
+5.2%
102,631
-12.3%
0.00%0.0%
Q2 2017$2,307,000
-30.6%
117,060
-26.0%
0.00%
-33.3%
Q1 2017$3,323,000
+26.4%
158,226
+13.2%
0.00%0.0%
Q4 2016$2,629,000
+28.1%
139,809
+42.3%
0.00%
+50.0%
Q3 2016$2,053,000
-39.0%
98,284
-25.5%
0.00%
-50.0%
Q2 2016$3,364,000
+44.0%
131,888
+49.4%
0.00%
+33.3%
Q1 2016$2,336,000
-9.9%
88,280
+45.7%
0.00%0.0%
Q4 2015$2,592,000
+17.7%
60,590
-27.1%
0.00%0.0%
Q3 2015$2,203,000
-40.3%
83,088
-25.0%
0.00%
-25.0%
Q2 2015$3,691,000
+68.5%
110,764
+68.4%
0.00%
+100.0%
Q1 2015$2,190,000
-29.8%
65,793
-13.8%
0.00%
-33.3%
Q4 2014$3,119,000
-12.5%
76,321
-27.4%
0.00%0.0%
Q3 2014$3,563,000
+35.9%
105,159
+35.3%
0.00%
+50.0%
Q2 2014$2,621,000
+68.9%
77,740
+90.0%
0.00%0.0%
Q1 2014$1,552,000
-71.8%
40,914
-78.3%
0.00%
-60.0%
Q4 2013$5,505,000
+199.3%
188,504
+250.6%
0.01%
+150.0%
Q3 2013$1,839,000
+79.9%
53,767
+73.5%
0.00%
+100.0%
Q2 2013$1,022,000
-60.2%
30,986
-61.4%
0.00%
-66.7%
Q1 2013$2,570,00080,2310.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 325,000$8,289,0002.39%
ARMISTICE CAPITAL, LLC 232,000$5,917,0002.25%
SENZAR ASSET MANAGEMENT, LLC 358,191$9,135,662,0001.99%
SCOPIA CAPITAL MANAGEMENT LP 3,171,229$80,882,0001.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,029,410$26,255,0001.03%
Baker Brothers Advisors 3,661,082$93,376,0000.98%
ARBOR CAPITAL MANAGEMENT LLC 58,783$1,499,0000.79%
Spark Investment Management LLC 292,400$7,457,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 98,000$2,499,0000.65%
Virtus ETF Advisers LLC 21,130$539,0000.40%
View complete list of ACORDA THERAPEUTICS INC shareholders